| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.34 | 0.08 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |